New cell therapy trial offers hope for kids with tough leukemia
NCT ID NCT07406178
Summary
This early-stage trial is testing a new cell therapy called JY509 for children and teenagers (ages 3-18) whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to standard treatments. The study will give participants an injection of universal natural killer (NK) cells to see if it's safe and if it can help control the cancer. Researchers will carefully monitor patients for side effects and signs that the treatment is working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY PEDIATRIC B-ALL are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.